Efficacy and Safety of LX102 Gene Therapy in Patients With Neovascular Age-related Macular Degeneration (nAMD) (STELLAR)

Clinical trial NCT07317934 · RECRUITING

Trial details

NCT number: NCT07317934
Sponsor: Innostellar Biotherapeutics Co.,Ltd
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Neovascular Age-Related Macular Degeneration (nAMD)Wet AMD

Start date: 2026-01-14
Primary completion: 2028-03-01
Enrollment: 388

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.